|
ΒΙΒΛΙΟΓΡΑΦΙΚΕΣ ΑΝΑΦΟΡΕΣ: 1. Papatheodoridis G et al Liver Int. 2023 Sep;43(9):1879-1889" 2. Yurdaydin C. Treatment of chronic delta hepatitis. Semin Liver Dis. 2012;32(3):237-244. doi:10.1055/s-0032-1323629 3. Wedemeyer H, Hardtke S, Manns MP. Treatment of hepatitis delta. Clin Liv Dis. 2013;2(6):237-239. 4. Farci P, Niro AG. Current and future management of chronic hepatitis D. Gastroen- terol Hepatol (NY). 2018;14(6):342-351. 5. Turon-Lagot V, Saviano A, Schuster C, Baumert TF, Verrier ER. Targeting the host for new therapeutic perspectives in hepatitis D. J Clin Med. 2020;9(1):222. doi:10.3390/jcm9010222 6. Urban S, Neumann-Haefelin C, Lamperti- co P. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult to treat disease. Gut. 2021;70(9):1782-1794. doi:10.1136/gutjnl-2020-323888
|
|
